Crinetics Pharmaceuticals CRNX Operating margin

Operating margin at other companies

Neurocrine BiosciencesNBIX

25.4%+4.9pp

Corcept TherapeuticsCORT

0.8%-13.5pp

BridgeBio PharmaBBIO

-90.5%-41.2pp

XER

Xeris Biopharma Holdings, Inc.XERS

10.9%+8.4pp

Amylyx Pharmaceuticals, Inc.AMLX

-47,349.8%-47,409pp

Eton Pharmaceuticals, Inc.ETON

-15.1%—

FAQ

What is Crinetics Pharmaceuticals's operating margin?

Crinetics Pharmaceuticals (CRNX) reported operating margin of -3,020.3% in Q1 2026.

How has Crinetics Pharmaceuticals's operating margin changed year-over-year?

Crinetics Pharmaceuticals's operating margin increased by 93.9% year-over-year, from -49,569.7% to -3,020.3%.

What is the long-term trend for Crinetics Pharmaceuticals's operating margin?

Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's operating margin has grown at a -9.5% compound annual growth rate (CAGR), from -9,990.9% to -6,714.8%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.